Clinical Trial Update: Neurocognitive Effectiveness in Treatment of First-episode Non-affective Psychosis: 3-years Follow-up [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update assessing neurocognitive effectiveness in treatment of first-episode non-affective psychosis with a 3-year follow-up.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psychosis
• Psychotic Disorders
• Schizophrenia

Snippet

Sponsor: Fundación Marques de Valdecilla | Conditions: Schizophrenia, Psychotic Disorders | Phase 4 | Status: UNKNOWN